Floatz logo

(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE

Pain, Intractable

University Hospitals Cleveland Medical CenterSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Pain, Intractable cohort.

Asset / SponsorPhaseRating
NEPENTHE
University Hospitals Cleveland Medical Center
Phase 4BB
Oxycodone
University Hospitals Cleveland Medical Center
Phase 4BB
Pregabalin
VA Office of Research and Development
Phase 4BB
FENTANYL
Janssen Pharmaceutical K.K.
Phase 3BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Haukeland University Hospital
Phase 3B

View all 20 →

Same molecule, other indications

(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:

Pain, PostoperativeDormant
BBB
Indicative ·
78 / 100
View asset →
Anesthesia, LocalDormant
BBB
Indicative ·
76 / 100
View asset →
neuralgiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →